The world can be a dangerous place whether you are out walking or living alone. Protecting yourself from attacks, emergencies or other calamities isn't always that easy if there is no one around to help.  Unintentional falls in the home are a major concern, being the number one cause of injury and death among people 65 and older. Safety concerns exist for individuals of all ages as they navigate life. Some 40% of Americans polled by Gallup said they would be scared walking alone at night in their neighborhoods; a thirty-year high To address those concerns, companies are churning out remote monitoring devices, going after a market forecast to grow at a CAGR of 11.2% between now and 2028. But many are singularly focused, catering either to the aging population or to people who don't feel safe in parking lots, getting in a ride-share or walking alone One company going against the grain by offering solutions to both groups is LogicMark Inc. LGMK. The maker of personal emergency response systems (PERS), health communications devices and IoT technologies has a suite of products designed to create a connected care platform that can help whether you are at home or out and about The company's built-in patented fall detection technology detects falls and sudden movements, triggering an alert for help. Thanks to LogicMark's geofencing technology, caregivers also receive alerts if their loved one moves beyond a virtual geographic boundary. GPS location service pinpoints exactly where a device is, sending help when the user is unable to speak or respond

Tesla Inc.’s TSLA sales in China and worldwide will likely set new records in the last quarter but not enough to avoid a decline in full-year sales, according to researcher Troy Teslike. What Happened: Tesla has to deliver at least 514,926 in the last quarter if it is to beat its 2023 delivery number of nearly 1.81 million According to Teslike, both China and global sales are expected to set new records in the fourth quarter. Tesla’s highest quarterly delivery number to date was in the last quarter of 2023 when the company delivered 484,507 vehicles worldwide “This quarter should be higher than that. Unfortunately, that’s not enough to avoid a decline in total yearly sales,” Teslike said. According to the researcher, Tesla’s Model Y sales in the U.S. and sales in Europe are down this quarter as compared to the corresponding period last year Quarterly deliveries of below 500,000, however, would be “disappointing,” he added

Even as Bitcoin BTC/USD crossed $88,000, up nearly 11% in 24 hours and over 30% the past week, experts say that "euphoria has set into the market," suggesting prices could reach $100,000 before encountering serious resistance. This rise has fueled significant liquidations totaling $655.12 million across long and short positions, sparking conversation about the factors driving Bitcoin's rally and its potential trajectory. BTC had set an all-time high of $88,364 at the time of publication According to data from CoinGlass, shorts worth $341.88 million got liquidated over the past 24 hours Speaking with Benzinga, Azeem Khan, co-founder of Morph, said, "Now that Bitcoin has crossed $85k, we're absolutely at the place where euphoria has set into the market." He cautioned against further buying due to the high likelihood of a future correction However, he added, "Where it goes from there is hard to say… since we're so early in euphoria I'd say we're back at the place where people who don't care about crypto from our families will be asking us what tokens to buy."

Society's tastes and preferences are constantly changing; as such, the most forward-thinking companies strive to anticipate where new preferences may manifest and to be present for interested consumers. In the beverage industry, non-alcoholic beers and wines are gaining prominence amongst consumers, opening the pathway for beverage producers to offer new and refreshing products akin to alcoholic beverages, but without their undesirable effects or long-term health consequences. Striving to become a key player in the non-alcoholic beverage market, Innovation Beverage Group IBG stands out as a developer, manufacturer and marketer of a diverse beverage portfolio. With 60 formulations across 13 alcoholic and non-alcoholic brands, the company is striving to be at the forefront of catering to evolving consumer preferences According to research by Introspective Market Research (IMR), the global non-alcoholic beer and wine market was estimated at $22.65 billion in 2022 and is projected to reach $37.21 billion by 2030, growing at a CAGR of 6.4%. While once considered a niche market, non-alcoholic beers and wines have become a material opportunity for beverage producers, but why is the question? The answer is varied While changes in societal preference and attitudes toward alcohol consumption is an overarching rationale, there are other reasons many people are making this change. As detailed in IMR's report, the rising health consciousness among consumers is arguably the primary reason behind the growth of the non-alcohol beer and wine market Technology and product innovation are also driving the growth of the non-alcoholic beverage category. As outlined in the IMR report, leading companies are making the necessary investments to compete in this category, using industry-leading processes, such as vacuum distillation and fermentation control, to create non-alcoholic beers and wines that closely replicate the flavor profiles of traditional alcoholic beverages. This technological advancement has played a crucial role in enhancing product quality and gaining consumer acceptance, propelling the market forward

Home Depot Inc HD stock is trading higher after the home improvement retailer beat its third-quarter earnings estimates and lifted its full-year 2024 outlook. HD reported third-quarter sales growth of 6.6% year-over-year to $40.217 billion, beating the consensus estimate of $39.173 billion Customer transactions for the quarter fell slightly by 0.2%. Comparable sales decreased 1.3%, and comparable sales in the U.S. dropped 1.2% Gross profit rose 5.4% YoY to $13.425 billion, with a margin of 33.4%, down 40 bps YoY. The operating margin was 13.5%, down 86 bps YoY, and operating income for the quarter dropped 0.22% to $5.418 billion. The adjusted operating margin slipped to 13.8% from 14.5% YoY The average ticket in the third quarter was $88.65, a 0.8% decrease, and sales per retail square foot declined 2.1% to $582.97

Wall Street saw the first surge in risk aversion after Donald Trump's election victory last week, as concerns grew over potential tariffs and trade policy shifts spurred by the incoming administration's key appointments. Trump is reportedly considering Sen. Marco Rubio (R-Fla.) for secretary of state and Rep. Mike Waltz (R-Fla.) for national security advisor. Both are vocal hawks on China and NATO, raising concerns of a tougher U.S. stance that could strain key geopolitical and trade relationships Adding to the cautious sentiment, investors are bracing for Wednesday's key inflation data release, with economists forecasting the annual rate to hit 2.6% in October As of midday trading in New York, none of the major U.S. equity indices posted gains, while small caps underperformed, with the Russell 2000 down 1.5%. Ten out of 11 S&P 500 sectors traded in the red, with consumer staples the only marking tiny gains The dollar, viewed as a hedge against tariff risk, strengthened, with a currency-weighted index reaching its highest level since May 2024

When it comes to trading, speed is of the essence. To be successful, traders need access to fast trading platforms, customizable tools and deep insights into market moves. The Trading Pit, a proprietary trading firm, knows that – which is why it just added integration with NinjaTrader to its arsenal of trading platforms.  It makes sense that The Trading Pit would integrate with the NinjaTrader platform. After all, NinjaTrader has a reputation in the market for its speed, efficiency and customizable features, reports The Trading Pit. NinjaTrader is also something the trading firm says customers were clamoring for, and since it's committed to giving its prop traders what they want, integration with NinjaTrader was a no-brainer "Traders have shown great enthusiasm for the NinjaTrader platform, renowned for its speed, efficiency and customizable features," wrote The Trading Pit when announcing the integration. "At The Trading Pit, we've always prioritized listening to our community, and this integration is a clear reflection of that commitment. By offering NinjaTrader with its Prime Futures challenges, The Trading Pit provides prop traders with the precision and control needed to excel in the competitive futures market." The Trading Pit is committed to meeting the demands of its traders. To learn more about its offering, click here. What The Trading Pit says sets NinjaTrader apart from its rivals is its advanced functionalities that enable futures traders to execute strategies with accuracy and precision, tailor trading environments to individual preferences and gain deeper insights into market movements. Combine that with The Trading Pit's other integrations, including Tradovate, which is a commission-free futures trading platform and TradingView, which provides charting and analysis tools, and The Trading Pit says it marks the beginning of a new chapter for the trading firm. One in which innovation meets trader-focused solutions

Risk assets have surged since Donald Trump's 2024 presidential win, fueled by investor optimism for tax cuts and renewed hopes of financial sector deregulation. Yet, markets may face a reality check on Wednesday when October inflation data is released, as signs of lingering price pressures could cool the recent euphoria and shake expectations for the Federal Reserve’s interest rate cuts. Economists predict that October's Consumer Price Index (CPI) data will show a modest uptick in inflation, potentially halting the downward trend observed over the past six months The economist consensus points to a 2.6% year-over-year rise in headline inflation, up from 2.4% in September On a monthly basis, headline inflation is expected to rise by 0.2%, in line with September’s reading. Meanwhile, core inflation—which excludes volatile food and energy prices and provides a clearer view of underlying price pressures—is forecasted to remain steady at 3.3% year-over-year, with a 0.3% monthly gain

Editor’s note: This story has been updated to more accurately report a quote from Chris Christie that states he is not in favor of cannabis descheduling. "The U.S. government has got to get its act together and decide what it really thinks on this issue," says Chris Christie, former New Jersey governor and longtime conservative voice, addressing the state of cannabis in America under a new Trump administration In an exclusive conversation with Benzinga Cannabis facilitated by Covers.com, Christie outlines his perspectives on the future of cannabis regulation and cryptocurrency adoption, framing both within a broader trend of deregulation he expects to see under Trump's leadership. As the country moves forward, Christie believes cannabis and crypto are poised to experience significant changes though each industry will need to navigate its own unique challenges Christie begins by tackling the complexities surrounding cannabis regulation, a topic he's been openly conservative about throughout his political career. Although he's traditionally opposed to federal legalization, Christie notes a potential shift under President-elect Donald Trump. "What I suspect he would really like to do is get it downgraded by the DEA so that it’s not illegal," Christie says. Cannabis remains a Schedule I substance, making it federally illegal despite a growing wave of state-level legalization. For Christie, the legal status presents an obstacle for the industry, particularly regarding banking and financial services. "The trouble the cannabis industry has now is that a lot of people still won't do business with them, because the proceeds are tainted by the fact they are created through a drug that is illegal in the United States." Beyond cannabis, Christie also weighs in on another hot-button topic: cryptocurrency. Known for its volatility and potential for high returns, crypto has seen a significant uptick in adoption over recent years. With Trump heading to the White House, Christie predicts a favorable environment for crypto's continued expansion. "I think it will develop because he’ll not be in favor of doing a lot of regulating on it," he says, suggesting that Trump's general stance on deregulation could encourage further growth in the crypto sector

From clinical developments to an upcoming FDA trial anticipated in 2025, Mainz Biomed NV MYNZ, the molecular genetics diagnostic company, is making headway in growing its business on its path to profitability.  ColoAlert®, its flagship product, is a key driver of its growth. Aimed at revolutionizing the colorectal cancer testing industry, ColoAlert is an early detection screening that spots bleeding and non-bleeding tumors through tumor DNA analysis. ColoAlert analyzes samples for the four tumor markers associated with cancer: KRAS-mutation, BRAF-mutation, total amount of human DNA and occult blood. By analyzing tumor DNA, Mainz says ColoAlert detects 85% of colorectal cancer cases, often in the very early stages of the disease, compared to the closest US competitor, Exas Science, delivering only 43% of Sensitivity for Advanced Adenomas. That is a key edge for the company, given the company says 71% of diagnoses made are in the later stages of the disease The product appears to be making inroads, with the company demonstrating at two conferences what it says are significant clinical successes in U.S. and European trials. Presentations at Digestive Disease Week – the meeting for professionals working in gastroenterology, hepatology, GI endoscopy, gastrointestinal surgery and related fields – and the American Society of Clinical Oncology meeting highlighted ColoAlert's success Mainz Biomed said in presentations that based on trials, ColoAlert's sensitivities exceeded 90% for detecting colorectal cancer and over 80% for advanced adenomas. Detecting advanced adenomas is crucial in preventing colorectal cancer, as identifying patients with these lesions allows for timely intervention through colonoscopy and adenoma removal, thereby averting cancer development, reports Mainz. The company was also awarded as a Poster of Distinction by the Digestive Disease Week judges for the presentation of industry-leading results "As we enter a critical phase in our company's journey, Mainz Biomed's vision remains focused on leading the way in cancer diagnostics," said Guido Baechler, CEO of Mainz Biomed. "Our groundbreaking clinical results with our mRNA based next generation CRC screening test and our strategic pathway to FDA trials, which we plan to start in 2025, demonstrate our commitment to expanding into the world's largest healthcare market. These efforts, combined with our growing international footprint, underscore why we believe Mainz Biomed is currently undervalued relative to its potential."